HBM BioVentures is a leading venture capital company with a carefully selected, diversified portfolio of some 35 investments in private and public enterprises in the biotechnology/human medicine, diagnostics and medical technology sectors. HBM BioVentures takes an active long-term role in its portfolio companies in order to support their value creation over an investment holding period of several years. HBM BioVentures is neither a passive investment fund nor a stock trader, but takes an entrepreneurial stance towards its portfolio companies. The investment process rigorously follows three key steps:HBM BioVentures selects qualityHBM BioVentures' investment advisors and external experts perform thorough due diligence on scientific, business/financial/patent and tax/legal issues surrounding attractive potential portfolio companies.
View Top Employees from HBM BioVenturesWebsite | http://www.hbmbioventures.com |
Revenue | $1 million |
Employees | View employees |
Industry | Finance General, Finance |
SIC | SIC Code 6799 Companies, SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 523 Companies |
Looking for a particular HBM BioVentures employee's phone or email?
The HBM BioVentures annual revenue was $1 million in 2024.
HBM BioVentures is based in Zurich, Zurich.
The NAICS codes for HBM BioVentures are [52, 523].
The SIC codes for HBM BioVentures are [6799, 679, 67].